Lower riskDrug recall · FDA · Published June 24, 2022
Noven Daytrana patches recalled due to ripping and adhesive issues
Noven Pharmaceuticals recalls Daytrana patches after customer complaints about ripping and adhesive transfer problems. This medication, used for ADHD, requires prescription and has a specific delivery system.
“Noven Daytrana patches recalled due to ripping and adhesive issues.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/34509-noven-daytrana-patches-recalled-due-to-ripping-and-adhesive-issues. Based on FDA recall #D-1169-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1169-2022%22&limit=1).
The FDA announced on June 24, 2022, that Noven Pharmaceuticals Inc is voluntarily recalling Daytrana (methylphenidate transdermal system) due to a defective delivery system. The recall affects 8,559 cartons distributed nationwide.
According to the FDA, customer complaints were received regarding ripping patches and tight release/adhesive transfer issues with the product.
Context
GovInfoNow's records show Noven Pharmaceuticals Inc has had 24 other recalls on record since July 5, 2011. Other recent recalls of similar products include Noven Xelstrym 13.5mg Transdermal System Recall (Oct. 31, 2024), Noven Daytrana 10mg Transdermal System Recall (March 10, 2023), and Noven Daytrana patches recalled due to defective adhesive delivery (Nov. 16, 2022). Other recent recalls of similar products include Blossom Pharmaceuticals Dynagel Wound Hydrogel Recall (Oct. 31, 2025), Wells Pharma Fentanyl Citrate Injectable Solution Recall (April 1, 2026), and Preferred Pharma Recalls Ondansetron ODT Due to Defective Seals (Nov. 17, 2025).
How to tell if you have this one
Check for Daytrana patches with NDC 68968-5552-3 and expiration date 12/22. The product was manufactured by Noven Pharmaceuticals Inc in Miami, FL.
Brand
Noven
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the NDC number 68968-5552-3 and expiration date 12/22 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 12 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1169-2022 (June 24, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1169-2022 to see it in context.
Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.